• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-34与胃肠道癌症:一个功能强大的参与者。

MicroRNA-34 and gastrointestinal cancers: a player with big functions.

作者信息

Gao Wei, Zhou Jianping, Morshedi Mohammadamin

机构信息

Department of Gastrointestinal and Hernia and Abdominal Wall Surgery, The First Hospital, China Medical University, Shenyang, 110001, China.

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.

出版信息

Cancer Cell Int. 2024 May 9;24(1):163. doi: 10.1186/s12935-024-03338-w.

DOI:10.1186/s12935-024-03338-w
PMID:38725047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11084024/
Abstract

It is commonly assumed that gastrointestinal cancer is the most common form of cancer across the globe and is the leading contributor to cancer-related death. The intricate mechanisms underlying the growth of GI cancers have been identified. It is worth mentioning that both non-coding RNAs (ncRNAs) and certain types of RNA, such as circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and microRNAs (miRNAs), can have considerable impact on the development of gastrointestinal (GI) cancers. As a tumour suppressor, in the group of short non-coding regulatory RNAs is miR-34a. miR-34a silences multiple proto-oncogenes at the post-transcriptional stage by targeting them, which inhibits all physiologically relevant cell proliferation pathways. However, it has been discovered that deregulation of miR-34a plays important roles in the growth of tumors and the development of cancer, including invasion, metastasis, and the tumor-associated epithelial-mesenchymal transition (EMT). Further understanding of miR-34a's molecular pathways in cancer is also necessary for the development of precise diagnoses and effective treatments. We outlined the most recent research on miR-34a functions in GI cancers in this review. Additionally, we emphasize the significance of exosomal miR-34 in gastrointestinal cancers.

摘要

人们普遍认为,胃肠道癌是全球最常见的癌症形式,也是癌症相关死亡的主要原因。胃肠道癌生长背后的复杂机制已被确定。值得一提的是,非编码RNA(ncRNAs)和某些类型的RNA,如环状RNA(circRNAs)、长链非编码RNA(lncRNAs)和微小RNA(miRNAs),都可能对胃肠道(GI)癌的发展产生重大影响。作为一种肿瘤抑制因子,miR-34a属于短链非编码调节RNA。miR-34a通过靶向多个原癌基因,在转录后阶段使其沉默,从而抑制所有与生理相关的细胞增殖途径。然而,已经发现miR-34a的失调在肿瘤生长和癌症发展中发挥重要作用,包括侵袭、转移以及肿瘤相关的上皮-间质转化(EMT)。进一步了解miR-34a在癌症中的分子途径对于精准诊断和有效治疗的发展也很有必要。在这篇综述中,我们概述了miR-34a在胃肠道癌中功能的最新研究。此外,我们强调了外泌体miR-34在胃肠道癌中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/2ad8f8270d26/12935_2024_3338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/3d81ed173b71/12935_2024_3338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/bc3b7f25c96a/12935_2024_3338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/2ad8f8270d26/12935_2024_3338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/3d81ed173b71/12935_2024_3338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/bc3b7f25c96a/12935_2024_3338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/11084024/2ad8f8270d26/12935_2024_3338_Fig3_HTML.jpg

相似文献

1
MicroRNA-34 and gastrointestinal cancers: a player with big functions.微小RNA-34与胃肠道癌症:一个功能强大的参与者。
Cancer Cell Int. 2024 May 9;24(1):163. doi: 10.1186/s12935-024-03338-w.
2
MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.miRNA-34a:一种在多种癌症中调控众多靶标的多功能调节剂。
Int J Mol Sci. 2017 Oct 2;18(10):2089. doi: 10.3390/ijms18102089.
3
Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential.miR-34a 在 EMT、ceRNA 海绵作用及其治疗潜力中的作用
Int J Mol Sci. 2019 Feb 16;20(4):861. doi: 10.3390/ijms20040861.
4
Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications.miR-34a在癌症中的多功能作用:一篇重点关注头颈部鳞状细胞癌和甲状腺癌并具有临床意义的综述
Diagnostics (Basel). 2020 Aug 5;10(8):563. doi: 10.3390/diagnostics10080563.
5
MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.微小RNA-34a作为一种抗转移微小RNA发挥作用,并通过直接靶向CD44抑制膀胱癌中的血管生成。
J Exp Clin Cancer Res. 2014 Dec 31;33(1):779. doi: 10.1186/s13046-014-0115-4.
6
MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle.微小RNA-155及其外泌体形式:胃肠道癌谜团中的小碎片
Cell Biol Toxicol. 2024 Sep 16;40(1):77. doi: 10.1007/s10565-024-09920-2.
7
Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells.环状 RNA 作为胃肠道肿瘤细胞上皮-间充质转化的关键调控因子。
Pathol Res Pract. 2023 May;245:154472. doi: 10.1016/j.prp.2023.154472. Epub 2023 Apr 20.
8
MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.微小RNA-34a靶向上皮-间质转化诱导转录因子(EMT-TFs),并抑制乳腺癌细胞的迁移和侵袭。
Oncotarget. 2017 Mar 28;8(13):21362-21379. doi: 10.18632/oncotarget.15214.
9
miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.Per1的miR-34a依赖性过表达可降低胆管癌的生长。
J Hepatol. 2016 Jun;64(6):1295-304. doi: 10.1016/j.jhep.2016.02.024. Epub 2016 Feb 24.
10
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.环状 RNA hsa_circ_0008305(circPTK2)通过调控非小细胞肺癌中的 TIF1γ 抑制 TGF-β诱导的上皮-间充质转化和转移。
Mol Cancer. 2018 Sep 27;17(1):140. doi: 10.1186/s12943-018-0889-7.

引用本文的文献

1
Interplay between NETosis and the lncRNA-microRNA regulatory axis in the immunopathogenesis of cancer.中性粒细胞胞外陷阱形成(NETosis)与lncRNA-微小RNA调控轴在癌症免疫发病机制中的相互作用
J Physiol Biochem. 2025 May 13. doi: 10.1007/s13105-025-01082-x.
2
Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges.益生菌在结直肠癌预防和治疗中的作用:机制、益处与挑战
Discov Oncol. 2025 Mar 26;16(1):406. doi: 10.1007/s12672-025-01996-4.
3
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases.

本文引用的文献

1
The correlation between miR -34a-3p, miR -31, PLEK2 and the occurrence, development and prognosis of colorectal cancer.miR-34a-3p、miR-31、PLEK2 与结直肠癌发生、发展及预后的相关性。
Cell Mol Biol (Noisy-le-grand). 2022 May 22;68(1):192-200. doi: 10.14715/cmb/2022.68.1.23.
2
Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma.血清外泌体miR-34a作为肝细胞癌诊断和预后的潜在生物标志物。
J Cancer. 2022 Feb 21;13(5):1410-1417. doi: 10.7150/jca.57205. eCollection 2022.
3
Translational advances in pancreatic ductal adenocarcinoma therapy.
非编码RNA:癌症和炎症性疾病中新兴的生物标志物及治疗靶点
Front Oncol. 2025 Mar 10;15:1534862. doi: 10.3389/fonc.2025.1534862. eCollection 2025.
4
Exploring miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting.探索微小RNA疗法和肠道微生物群增强的嵌合抗原受体T细胞:推进胶质母细胞瘤干细胞靶向治疗的前沿进展。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2169-2207. doi: 10.1007/s00210-024-03479-9. Epub 2024 Oct 9.
胰腺导管腺癌治疗的转化进展。
Nat Cancer. 2022 Mar;3(3):272-286. doi: 10.1038/s43018-022-00349-2. Epub 2022 Mar 29.
4
Cell Cycle Regulation and DNA Damage Response Networks in Diffuse- and Intestinal-Type Gastric Cancer.弥漫型和肠型胃癌中的细胞周期调控与DNA损伤反应网络
Cancers (Basel). 2021 Nov 18;13(22):5786. doi: 10.3390/cancers13225786.
5
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.癌细胞和肿瘤微环境中的肿瘤抑制性miRNA:失调机制及临床意义
Front Oncol. 2021 Oct 15;11:708765. doi: 10.3389/fonc.2021.708765. eCollection 2021.
6
Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition.肿瘤来源的外泌体包裹 miR-34a 在体外条件下促进结直肠癌细胞的凋亡,并抑制其迁移和肿瘤进展。
Daru. 2021 Dec;29(2):267-278. doi: 10.1007/s40199-021-00400-0. Epub 2021 Aug 17.
7
Hsa-miR-34a-5p reverses multidrug resistance in gastric cancer cells by targeting the 3'-UTR of SIRT1 and inhibiting its expression.人源微小RNA-34a-5p通过靶向沉默信息调节因子1(SIRT1)的3'-非翻译区并抑制其表达来逆转胃癌细胞的多药耐药性。
Cell Signal. 2021 Aug;84:110016. doi: 10.1016/j.cellsig.2021.110016. Epub 2021 Apr 22.
8
Precision oncology in metastatic colorectal cancer - from biology to medicine.精准肿瘤学在转移性结直肠癌中的应用——从生物学到医学。
Nat Rev Clin Oncol. 2021 Aug;18(8):506-525. doi: 10.1038/s41571-021-00495-z. Epub 2021 Apr 16.
9
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.生物标志物靶向治疗晚期胃癌和胃食管交界癌:一种新兴模式。
Nat Rev Clin Oncol. 2021 Aug;18(8):473-487. doi: 10.1038/s41571-021-00492-2. Epub 2021 Mar 31.
10
miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells.miR-34a模拟物或前体miR-34a,哪种是癌症治疗的更佳选择?以KatoIII作为研究miRNA在人胃癌细胞中作用的模型。
Cancer Cell Int. 2021 Mar 19;21(1):178. doi: 10.1186/s12935-021-01872-5.